| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/24/2000 | EP1002081A2 Delayed progression to aids by a missense allele of the ccr2 gene |
| 05/24/2000 | EP1002054A1 Process for the production of virus in cell cultures |
| 05/24/2000 | EP1002052A1 Novel lactic acid bacteria |
| 05/24/2000 | EP1002051A2 PROBIOTIC STRAINS FROM $i(LACTOBACILLUS SALIVARIUS) AND ANTIMICROBIAL AGENTS OBTAINED THEREFROM |
| 05/24/2000 | EP1001979A1 Cyclic azapeptides with angiogenic effect |
| 05/24/2000 | EP1001967A1 Componds and methods for treating and screening viral reactivation |
| 05/24/2000 | EP1001951A1 Thiazole derivatives, method for their production and use |
| 05/24/2000 | EP1001933A1 Caspases and apoptosis |
| 05/24/2000 | EP1001815A1 Vectors derived from antibodies for transferring substances into cells |
| 05/24/2000 | EP1001813A1 Pharmaceutical formulations containing voriconazole |
| 05/24/2000 | EP1001808A1 Adjuvant compositions for vaccines |
| 05/24/2000 | EP1001807A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases |
| 05/24/2000 | EP1001806A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 05/24/2000 | EP1001805A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
| 05/24/2000 | EP1001804A1 Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections |
| 05/24/2000 | EP1001801A1 Product comprising at least a double stranded rna combined with at least an antiviral agent |
| 05/24/2000 | EP1001800A2 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 05/24/2000 | EP1001798A1 Method for preventing or treating a human immunodeficiency virus infection |
| 05/24/2000 | EP1001797A1 Soya extract, process for its preparation and pharmaceutical composition |
| 05/24/2000 | EP1001789A1 Product comprising at least a double stranded rna combined with at least a 6-benzyluracil derivative |
| 05/24/2000 | EP1001786A1 Method of treating rhinoviral infections |
| 05/24/2000 | EP1001782A1 5,6-HETEROARYL-DIPYRIDO 2,3-$i(b):3',2'-$i(f)]AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION |
| 05/24/2000 | EP1001778A1 Use of a rifamycin derivative for treating mastitis in a domestic animal |
| 05/24/2000 | EP1001767A1 Anti-viral compounds |
| 05/24/2000 | EP1001766A1 Compounds and methods |
| 05/24/2000 | EP1001759A2 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 05/24/2000 | EP0787135B1 Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer |
| 05/24/2000 | EP0781353A4 System for electrolyzing fluids for in vivo administration to humans and other warm blooded mammals |
| 05/24/2000 | EP0769017B1 Therapeutic compounds |
| 05/24/2000 | EP0725629B1 Liposomal defensins |
| 05/24/2000 | EP0671879B1 Prevention of injury and degeneration of photoreceptors by neurotrophic factors |
| 05/24/2000 | EP0497911B1 Recombinant production of lactoperoxidase |
| 05/24/2000 | CN1254335A Nicotinamide derivatives |
| 05/24/2000 | CN1254333A Immunotherapeutic imides/amides |
| 05/24/2000 | CN1254292A Anti-helicobacter vaccine composition for use by subdiahragmatic systemic route, and combined mucosal/parenteral immunization method |
| 05/24/2000 | CN1254282A Benzimidazole-2-carbamates for treatment of viral infections and cancer |
| 05/24/2000 | CN1254281A HIV and cancer treatment |
| 05/24/2000 | CN1253948A Substituted tricyclic compound |
| 05/24/2000 | CN1253829A Antiseptic Chinese medicine preparation and its preparation method |
| 05/24/2000 | CN1052731C Compounds with growth hormone releasing properties |
| 05/24/2000 | CN1052634C Anti-catching cold Chinese traditional medicine oral liquid and its preparing method |
| 05/23/2000 | US6066730 Boronic ester and acid compounds, synthesis and uses |
| 05/23/2000 | US6066720 Modified oligonucleotides, their preparation and their use |
| 05/23/2000 | US6066676 Pharmaceutical composition and methods for using it |
| 05/23/2000 | US6066656 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
| 05/23/2000 | US6066630 Cephalosporin antibiotics |
| 05/23/2000 | US6066620 Mixture with surfactant |
| 05/23/2000 | US6066617 Polypeptide |
| 05/23/2000 | US6066502 Endothelin converting enzyme (ECE) |
| 05/23/2000 | US6066498 Compositions for the treatment and diagnosis of immune disorders |
| 05/23/2000 | US6066465 Measuring concentration of cyclophilins in blood sample, comparing to control, and evaluating degree of shock by increase of cytophilin concentration over control levels |
| 05/23/2000 | US6066447 Including nucleoside dimers with modified backbones; for viricides and antisense agents |
| 05/23/2000 | US6066324 Carboxyl terminal of papilloma virus L1 region is not required for formation of virus-like particles |
| 05/23/2000 | US6066323 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents |
| 05/23/2000 | US6066322 Administering antibody to treat asthma; treating helper t-cell mediated conditions |
| 05/23/2000 | US6066320 Isolating antiserum with nerve cells presenting anti-prion protein |
| 05/23/2000 | US6066319 Administering membrane attack complex (mac) transmembrane channel forming agent which is an antibody simultaneously therewith an effective amount of a therapeutic or diagnostic agent |
| 05/23/2000 | CA2290197A1 Vaccine against swine influenza virus |
| 05/23/2000 | CA2072125C Design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 05/23/2000 | CA2066998C Recombinant varicella-zoster virus and process for constructing same |
| 05/23/2000 | CA2066997C Antimicrobial peptide and antimicrobial agent |
| 05/18/2000 | WO2000028075A1 Bacillus strain and assay methods |
| 05/18/2000 | WO2000028074A1 Screening process for antibacterial agents |
| 05/18/2000 | WO2000028064A1 Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 05/18/2000 | WO2000028039A2 Identification of senv genotypes |
| 05/18/2000 | WO2000028038A2 Virulence genes and proteins, and their use |
| 05/18/2000 | WO2000028037A1 CATFIIIA CANDIDA ALBICANS tfIIIA GENE (CatfIIIA) AND THE CODED CATFIIIA PROTEIN |
| 05/18/2000 | WO2000028035A1 CHEMOKINE β-7 |
| 05/18/2000 | WO2000028016A1 T cells specific for target antigens and methods and vaccines based thereon |
| 05/18/2000 | WO2000028010A2 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 05/18/2000 | WO2000028004A1 Virus vectors and methods of making and administering the same |
| 05/18/2000 | WO2000028003A1 Avipox vector coding an hiv antigen and a cytokine |
| 05/18/2000 | WO2000028001A1 Modified exosomes and uses |
| 05/18/2000 | WO2000027880A2 Rantes-derived peptides with anti-hiv activity |
| 05/18/2000 | WO2000027857A2 Novel erythromycin derivatives, preparation method and use as medicines |
| 05/18/2000 | WO2000027852A1 Novel imidazo[5,1-b]thiazole derivatives and fungicides containing the same as the active ingredient |
| 05/18/2000 | WO2000027830A1 Thiocarbamic acid derivatives |
| 05/18/2000 | WO2000027828A2 2,4-disubstituted triazine derivatives with anti hiv activity |
| 05/18/2000 | WO2000027825A1 Hiv replication inhibiting pyrimidines |
| 05/18/2000 | WO2000027811A1 Neurotrophic diamide and carbamate agents |
| 05/18/2000 | WO2000027432A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 05/18/2000 | WO2000027430A2 Composition consisting of influenza virus surface proteins and dispensing device |
| 05/18/2000 | WO2000027429A2 Vaccine against papillomatous digital dermatitis (pdd) |
| 05/18/2000 | WO2000027427A1 trmD |
| 05/18/2000 | WO2000027422A2 Methods and compositions for treating or preventing peripheral neuropathies |
| 05/18/2000 | WO2000027398A1 Pharmaceutical moxifloxacin preparation |
| 05/18/2000 | WO2000027390A1 Ionic silver complex |
| 05/18/2000 | WO2000027378A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 05/18/2000 | WO2000027369A1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 05/18/2000 | WO2000027363A1 Aerosols comprising nanoparticle drugs |
| 05/18/2000 | WO2000027359A1 An inhalation system |
| 05/18/2000 | WO2000027205A1 A recombinant polypeptide for use in the manufacture of vaccines against campylobacter induced diarrhea and to reduce colonization |
| 05/18/2000 | WO2000027204A1 Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the n-hydroxyanilide-type |
| 05/18/2000 | WO2000027196A1 Use of gm-csf to inhibit development of drug resistance in hiv+ patients |
| 05/18/2000 | WO2000009734A3 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 05/18/2000 | WO2000009553A3 Antimicrobial peptides isolated from the skin of american frogs |
| 05/18/2000 | WO2000009137A3 Aminosterol compounds and uses thereof |
| 05/18/2000 | WO2000006140A3 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 05/18/2000 | WO1999058096A3 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 05/18/2000 | DE19853998A1 Use of aloe vera extracts for the treatment and prevention of herpes and cytomegalovirus infection, stomatitis and skin irritation caused by UV light |